SECreport

Form 4 Nuo Therapeutics, Inc. For: Sep 19 Filed by: SHEEDY CHARLES E

NUO THERAPEUTICS INC NEW  (AURX) 
US:NASDAQ Investor Relations: nuot.com/investors